Association between the postprandial glucose levels and arterial stiffness measured according to the cardio-ankle vascular index in non-diabetic subjects

Internal Medicine

Volumn 54, Issue 16, 2015, Pages 1961-1969

  Tsuboi, Atsuko ^a,b   Ito, Chikako ^a   Fujikawa, Rumi ^a   Yamamoto, Hideya ^b   Kihara, Yasuki ^b  

^a Grand Tower Medical Court   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Arterial stiffness; Cardio ankle vascular index; Postprandial glucose

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGE; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR PARAMETERS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; AGED; ANKLE; ANKLE BRACHIAL INDEX; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; EPIDEMIOLOGY; HYPERGLYCEMIA; JAPAN; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POSTPRANDIAL STATE; PREDICTIVE VALUE; STATISTICS AND NUMERICAL DATA; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANKLE; ANKLE BRACHIAL INDEX; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; JAPAN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PREDICTIVE VALUE OF TESTS; VASCULAR STIFFNESS;

EID: 84939448744     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.3596     Document Type: Article

References (50)

1. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 23: 554-566, 2003.
2. Tanaka H, Muranaka M, Kawano Y, et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 27: 2022-2027, 2009.
3. Nye ER. The effect of blood pressure alteration on the pulse wave velocity. Br Heart J 26: 261-265, 1964.
4. Shirai K, Hiruta N, Song M, et al. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 18: 924-938, 2011.
5. Shirai K, Song M, Suzuki J, et al. Contradictory effects of ß1 and a1-aderenergic receptor blockers on cardio-ankle vascular index (CAVI). J Atheroscler Thromb 18: 49-55, 2011.
6. Ibata J, Sasaki H, Kakimoto T, et al. Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pr 80: 265-270, 2008.
7. Izuhara M, Shioji K, Kadota S, et al. Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ J 72: 1762-1767, 2008.
8. Okura T, Watanabe S, Kurata M, et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res 30: 335-340, 2007.
9. Takaki A, Ogawa H, Wakeyama T, et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J 71: 1710-1714, 2007.
10. Kadota K, Takamura N, Aoyagi K, et al. Availability of cardioankle vascular index (CAVI) as a screening tool for atherosclerosis. Circ J 72: 304-308, 2008.
11. Takaki A, Ogawa H, Wakeyama T, et al. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res 31: 1347-1355, 2008.
12. Kubozono T, Miyata M, Ueyama K, et al. Acute and chronic effects of smoking on arterial stiffness. Circ J 75: 698-702, 2011.
13. DECODE study group,the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Atch Intern Med 161: 397-405, 2001.
14. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22: 920-924, 1999.
15. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39: 1577-1583, 1996.
16. Cavalot F, Petreri A, Traversa M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 91: 813-819, 2006.
17. Schram MT, Henry RM, van Dijk RA, et al. Increased central artery stiffness in impaired glucose metabolism and type2 diabetes: the Hoorn Study. Hypertension 43: 176-181, 2004.
18. Kasayama S, Saito H, Mukai M, Koga M. Insulin sensitivity independently influences brachial-ankle pulse-wave velocity in nondiabetic subjects. Diabet Med 22: 1701-1706, 2005.
19. Choi ES, Rhee EJ, Choi JH, et al. The association of brachialankle pulse wave velocity with 30-minute post-challenge plasma glucose levels in korean adults with no history of type 2 diabetes. Korean Diabetes J 34: 287-293, 2010.
20. Sciacqua A, Maio R, Miceil S, et al. Association between onehour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS One 7: e44470, 2012.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
22. Kashiwagi A, Kasuga M, Araki E, et al; Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 3: 39-40, 2012.
23. Ebinuma H, Miyazaki O, Yago H, Hara K, Yamauchi T, Kadowaki T. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin Chim Acta 372: 47-53, 2006.
24. Hayashi K, Handa H, Nagasawa S, Okumura A, Moritake K. Stiffness and elastic behavior of human intracranial and extracranial arteries. J Biomech 13: 175-184, 1980.
25. Kawasaki T, Sasayama S, Yagi S, Asakawa T, Hirai T. Noninvasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovascular Res 21: 678687, 1987.
26. Bramwell JC, Hill AV. The velocity of the pulse wave in man. Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character 93: 298-306, 1922.
27. Shirai K, Utino J, Otsuka K, Tanaka M. A novel blood pressureindependent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 13: 101-107, 2006.
28. Tamada T, Iwasaki H. Age at natural menopause in Japanese women. Nihon Sanka Fujinka Gakkai Zasshi (Acta Obstetricaet Gynaecologica Japonica) 47: 947-952, 1995 (in Japanese, Abstract in English).
29. American Diabetes Association. Postprandial blood glucose (Consensus Statement). Diabetes Care 24: 775-778, 2001.
30. Takahashi K, Miura S, Mori-Abe A, et al. Impact of menopause on the augmentation of arterial stiffness with aging. Gynecol Obstet Inverst 60: 162-166, 2005.
31. Ledoux J, Werner ME, Brayden JE, Nelson MT. Calciumactivated potassium channels and the regulation of vascular tone. Physiology 21: 69-78, 2006.
32. 2+/EDRF signaling are due to generation of superoxide anions. Diabetes 45: 1386-1395, 1996.
33. Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 2528, 1997.
34. Ge QM, Dong Y, Zhang HM, Su Q. Effects of intermittent high glucose on oxidative stress in endothelial cells. Acta Diabetol 47: 97-103, 2010.
35. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116: 39-48, 2007.
36. Ohashi N, Yamamoto H, Horiguchi J, et al. Visceral fat accumulation as a predictor of coronary artery calcium as assessed by multislice computed tomography in Japanese patients. Atherosclerosis 202: 192-199, 2009.
37. Kashihara H, Lee JS, Kawakubo K, Tamura M, Akabayashi A. Criteria of waist circumference according to computed tomography-measured visceral fat area and the clustering of car diovascular risk factors. Circ J 73: 1881-1886, 2009.
38. Tsuriya D, Morita H, Horioka T, et al. Significant correlation between visceral adiposity and high-sensitivity C-reactive protein (hs-CRP) in Japanese subjects. Intern Med 50: 2767-2773, 2011.
39. Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51: 1596-1600, 2002.
40. Zarkesh M, Faam B, Daneshpour MS, Azizi F, Hedayati M. The relationship between metabolic syndrome, cardiometabolic risk factors and inflammatory markers in a Teheranian population: the Teheran Lipid and Glucose Study. Intern Med 51: 3329-3335, 2012.
41. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 36: 439-451, 2005.
42. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Atheroscler Thromb Vasc Biol 24: 2933, 2004.
43. Hara K, Horikoshi M, Yamauchi T, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the predictor of insulin resistance and metabolic syndrome. Diabetes Care 29: 1357-1362, 2006.
44. ParkHE,ChoiSY,KimHS,KimMK,ChoSH,OhBH.Epicardial fat reflects arterial stiffness: Assessment using 256 slice multidetector coronary computed tomography and cardio-ankle vascu lar index. J Atheroscler Thromb 19: 570-576, 2012.
45. Choi SY, Oh BH, Park JB, Choi DJ, Rhee MY, Park S. Ageassociated increase in arterial stiffness measured according to the cardio-ankle vascular index without blood pressure changes in healthy adults. J Atheroscler Thromb 20: 911-923, 2013.
46. Soska V, Frantisova M, Dobsak P, et al. Cardio-ankle vascular index in subjects with dyslipidemia and other cardiovascular risk factors. J Atheroscler Thromb 20: 443-451, 2013.
47. Kinouchi K, Ichihara A, Sakoda M, Kurauchi-Mito A, Murohashi-Bokuda K, Itoh H. Effects of termisartan on arterial stiffness assessed by the cardio-ankle vascular index in hypertensive patients. Kidney Blood Press Res 33: 304-312, 2010.
48. Sasaki H, Saiki A, Endo K, et al. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. J Atheroscler Thromb 16: 568-575, 2009.
49. Satoh N, Shimatsu A, Kotani K, et al. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome. Hypertens Res 32: 1004-1008, 2009.
50. Miyashita Y, Endo K, Saiki A, et al. Effect of ezetimibe monotherapyon lipid metabolism and arterial stiffness assessed by cardio-ankle vascular index in type 2 diabetic patients. J Atheroscler Thromb 17: 1070-1076, 2010.